LLLT to Reduce Low Back Pain

Inclusion Criteria: * Reporting a primary pain point in lower back. * Pain intensity reported at baseline must be 4 and above on the Visual Analogue scale (PROMIS Numeric Rating Scale). * Individual able to participate fully in all aspects of the study and have understood and signed study informed consent. Exclusion Criteria: * Have used pain medications or participated in a pain treatment within three days of study enrollment. * Have an implanted device (including lap band) in the targeted area of Low Level Laser Treatment. * Have used an investigational drug within 30 days of study enrollment. * Reports being currently pregnant, lactating, or are of child-bearing potential or are likely to become pregnant during the low level laser treatment phase and are unwilling to use a reliable form of contraception. Acceptable forms of contraception include: Hormonal methods, such as birth control pills, patches, injections, vaginal ring, or implants; Barrier methods (such as a condom or diaphragm) used with a spermicide (a foam, cream, or gel that kills sperm); Intrauterine device (IUD); Total hysterectomy or tubal ligation; Abstinence (no sex). * Have a history of any major cardiovascular events including heart valve disease, ongoing angina, cardiac arrhythmias, congestive heart failure, acute coronary syndrome, stroke, transient ischemic attack, or peripheral vascular disease. * Have clinically significant acute or chronic progressive or unstable neurologic, hepatic, renal, cardiovascular, lymphatic, respiratory, metabolic disease (such as uncontrolled diabetes type 2), active cancer, actively receiving l treatment for cancer or within 1 year of cancer remission. * Surgical intervention for pain within 1 month prior to enrollment. * Active infection, wound or other external trauma to the areas to be treated with the laser * Known photosensitivity disorder. * Have a known history of any condition or factor judged by the investigator to preclude participation in the study or which might hinder adherence.